share_log

T2 Biosystems | RW: Registration Withdrawal Request

SEC ·  May 15 05:00
Summary by Futu AI
T2 Biosystems, Inc., a medical diagnostic company, has formally requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on April 22, 2024. The company decided not to proceed with the offering that was contemplated in the Registration Statement. T2 Biosystems confirmed that no securities have been sold pursuant to the Registration Statement. The request for withdrawal was made effective immediately, as per the communication dated May 14, 2024. The company's legal counsel, Michael T. Gibbs, and representatives from Latham & Watkins LLP are handling the withdrawal process.
T2 Biosystems, Inc., a medical diagnostic company, has formally requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on April 22, 2024. The company decided not to proceed with the offering that was contemplated in the Registration Statement. T2 Biosystems confirmed that no securities have been sold pursuant to the Registration Statement. The request for withdrawal was made effective immediately, as per the communication dated May 14, 2024. The company's legal counsel, Michael T. Gibbs, and representatives from Latham & Watkins LLP are handling the withdrawal process.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.